MedTrace Logo

Virtual Reality Based Sensorimotor Speech Therapy

NCT02928822 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2018-07-12

No results posted yet for this study

Summary

The purpose of this study is to determine whether VR based language rehabilitation scenario based on the core premises of ILAT has a beneficial effect on the linguistic performance (faster retrieval of the target lexicon and general fluency) of Broca's aphasia patients. Furthermore, it aims at testing the effects of cueing (visual and auditory) on word retrieval.

Conditions

  • Broca's Aphasia

Interventions

BEHAVIORAL

VR-based sensorimotor aphasia therapy

VR-based sensorimotor aphasia therapy. 8 weeks, 1 session a week, 30min-1h per session of language and motor therapy using using VR rehabilitation gaming system. The patients will play in pairs.

BEHAVIORAL

Control Group (conventional aphasia rehabilitation)

8 weeks, 1 session a week, 30min-1h per session of conventional aphasia rehabilitation training the same vocabulary as the experimental group.

Sponsors & Collaborators

  • Hospital Universitari Joan XXIII de Tarragona.

    collaborator OTHER

  • Universitat Pompeu Fabra

    lead OTHER

Principal Investigators

  • Rosa Maria San Segundo Mozo, Dra. · Laboratory of Synthetic Perceptive, Emotive and Cognitive Systems

  • Rosa Maria San Segundo Mmozo, Dra. · Servicio de Medicina Fisica i Rehabilitacion de Joan XXII de Tarragona. 977295801

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2017-08-31
Completion
2018-04-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02928822 on ClinicalTrials.gov